# Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled Study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/hydroxychloroquine-in-the-treatment-of-covid-19-a-multicenter-randomized/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Sherief Abd‐Elsalam,Eslam Saber Esmail,Mai Khalaf,Ehab Fawzy Abdo,Mohammed A. Medhat,Mohamed Samir Abd El Ghafar,Ossama Ashraf Ahmed,Shaimaa Soliman,Ghada N. Serangawy,Mohamed Alboraie |
| Citations | 137 |
| DOI | 10.4269/ajtmh.20-0873 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.ajtmh.org/downloadpdf/view/journals/tpmd/103/4/article-p1635.pdf |
| OpenAlex ID | https://openalex.org/W3049278054 |
| PMID | 32828135 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Eslam Saber Esmail](https://scholariq.org/researchers/eslam-saber-esmail/)

## Paper primary topic

- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)

## Paper topics

- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [Long-Term Effects of COVID-19](https://scholariq.org/topics/long-term-effects-of-covid-19/)
- [Sepsis Diagnosis and Treatment](https://scholariq.org/topics/sepsis-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.